Riociguat in systemic sclerosis: a potential for disease modification.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the rheumatic diseases"
DOI: 10.1136/annrheumdis-2020-218180
Abstract: We read with great interest the results of the recently published Riociguat Safety and Efficacy in Systemic Sclerosis (RISE-SSc) trial1 and believe that additional analyses could further elucidate the role of riociguat in systemic sclerosis… read more here.
Keywords: sclerosis; disease modification; sclerosis potential; riociguat systemic ... See more keywords